Latest S-1 registration statements

Silo Pharma launches a public offering of common stock and warrants, aiming to raise approximately $4.3 million for working capital to support its biopharmaceutical development programs.

AgriFORCE Growing Systems has filed an amendment to its registration statement to allow selling stockholders to offer up to 9,698,474 shares of common stock for resale.

BIO-key International is registering for the resale of up to 3,091,668 shares of its common stock by a selling stockholder, with the company not receiving any proceeds from the sale.

Altisource Portfolio Solutions S.A. is registering up to 114,499,134 common shares for issuance upon the exercise of stakeholder warrants, aiming to reduce debt and for general corporate purposes.

Avidia Bancorp, Inc. is set to offer its common stock for sale in connection with the mutual-to-stock conversion of Assabet Valley Bancorp, aiming for a New York Stock Exchange listing under the symbol AVBC.

Propanc Biopharma amends its registration statement to offer common stock instead of units, targeting a Nasdaq listing to enhance market visibility.

Cyclacel Pharmaceuticals has filed a registration statement for the potential resale of over 170 million shares of its common stock by selling shareholders.

Lottery.com aims to raise $100 million by registering shares for sale under a stock purchase agreement with Generating Alpha Ltd.

Hyperscale Data, Inc. plans to raise up to $50 million through the sale of Series B Preferred Stock, alongside the resale of common stock issuable upon conversion of existing convertible notes.

Picard Medical, a medical technology company focused on artificial hearts, has filed an amendment to its S-1 registration statement, signaling progress towards its initial public offering and outlining plans for market expansion and product innovation.

Idaho Copper Corporation files an amendment to its registration statement for the potential resale of up to 94.1 million shares of common stock by selling stockholders.

BriaCell Therapeutics Corp. is registering additional securities for a proposed maximum aggregate offering price not to exceed $5,318,750.

Windtree Therapeutics is registering up to 31,247,383 shares of common stock for resale by selling stockholders, including shares issuable upon conversion of preferred stock, exercise of warrants, and under an equity line of credit agreement.

Intensity Therapeutics is planning a public offering of common stock and warrants to raise capital for clinical trials and general corporate purposes.

Lakeshore Acquisition III Corp., a blank check company, is set to launch a $60 million IPO to pursue a merger, share exchange, or asset acquisition with a target business across North America, South America, Europe, or Asia.

Copley Acquisition Corp files an amendment to its S-1 registration statement for a $150 million IPO, offering units with Class A shares and warrants.

BriaCell Therapeutics is launching a firm commitment public offering of common units and pre-funded units to raise capital for working capital, general corporate purposes, and business objectives.

Real Asset Acquisition Corp. files an amendment to its registration statement related to its initial public offering, detailing expenses, indemnification, unregistered securities sales, and exhibits.

Digital Asset Acquisition Corp. files an amendment to its registration statement related to its initial public offering.

Real Asset Acquisition Corp. files an amendment to its S-1 registration statement for a $150 million IPO, aiming to merge with companies in metals, mining, real estate, infrastructure, and related sectors.

Digital Asset Acquisition Corp., a blank check company, files an amendment to its S-1 registration statement for a $150 million IPO, aiming to merge with a company in the digital asset and cryptocurrency sectors.

Windtree Therapeutics is registering for resale up to 31.2 million shares of common stock by selling stockholders, including shares issuable upon conversion of preferred stock and notes, exercise of warrants, and under an equity line of credit.

NanoVibronix aims to secure up to $16 million via an offering of Series G Convertible Preferred Stock and accompanying warrants, with proceeds earmarked for Series X Preferred Stock redemption and general corporate needs.

Intensity Therapeutics is launching a public offering to sell shares of common stock and warrants, aiming to raise capital for clinical trials and general corporate purposes.

Healthcare Triangle, Inc. has filed an amendment to its Form S-1 registration statement to register up to 1,483,809,885 shares of common stock for resale by selling stockholders.

Fly-E Group, an electric vehicle company, plans to raise up to $8 million through a best-efforts offering of common stock and warrants to fund inventory, production, and general corporate purposes.

BriaCell Therapeutics launches a public offering of common and pre-funded units to bolster its clinical-stage immunotherapy programs.

Kairos Pharma is registering shares for resale by Helena Global Investment Opportunities I Ltd., potentially raising up to $15 million through an equity line of credit agreement.

Momentus Inc. has filed a registration statement for the potential resale of up to 2,142,858 shares of its Class A common stock by selling stockholders, stemming from the exercise of inducement warrants issued in March 2025.

Renatus Tactical Acquisition Corp I, a blank check company led by former Digital World Acquisition Corp. executives, filed an amended S-1 registration statement seeking to raise $175 million in an initial public offering to pursue business combinations in the cryptocurrency, data security, and dual-use technologies sectors in the United States.